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In This IssueMicropeptide’s Brawny Powers
PAGE 595
Anderson et al. identify a skeletal muscle-specific micropeptide called myoregulin,
encoded within a long noncoding RNA, that controls skeletal muscle function by
directly inhibiting the pump activity of the Ca2+-ATPase SERCA. Mice lacking myor-
egulin demonstrate improved intracellular calcium handling and exercise perfor-
mance.Gut-Level Individuality
PAGE 583
The species composition of gut microbiomes can differ markedly between individ-
uals. Greenblum et al. now uncover extensive variation within individual gut micro-
bial species in their gene composition and copy number and link these strain-level
differences to obesity and inflammatory bowel disease.Decoding a Long Noncoding Mystery
PAGE 607
EBER2 is a highly abundant noncoding RNA with unknown function that is expressed by the Epstein-Barr virus. Lee et al. find that
EBER2 localizes to specific repeat sites on viral chromatin to facilitate binding of its interacting host transcription factor PAX5 to these
sites. Recruitment of the EBER2-PAX5 complex depends upon RNA-RNA interactions between EBER2 and nascent transcripts that
together control the viral lytic cycle and infection.An Extracellular Stop to Influenza
PAGE 631
Interferon-stimulated genes (ISGs) act in concert to provide a tight barrier against viruses. Using a screen to identify ISGs inhibiting
late stages of the influenza A virus infection, Dittman et al. find that plasminogen activator inhibitor (PAI-1) blocks maturation of the
viral surface glycoprotein, thus reducing virus spread in the airways. These findings show that the innate immune system, driven by
type I interferon, uses modulation of the extracellular environment to inhibit viruses.Stress Test for RNA
PAGE 644
TheCCA-adding enzymemonitors the stability of tRNAs and tRNA-like small RNAs.WhereasCCA is added to stable RNAs, CCACCA
is added to unstable ones to initiate their degradation. Kuhn et al. now characterize how these two scenarios are distinguished.
Following CCA addition, stable RNAs are ejected, whereas unstable RNAs refold and are subjected to a second round of addition.
Therefore, RNAs proofread themselves through differential responses to the interrogation of the enzyme.Switching Speed with a Squeeze
PAGE 659 and PAGE 673
Fast amoeboid cell migration in 3D environments is central to developmental and disease-related processes, such as cancer metas-
tasis. Liu et al. and Rupretch et al. now find that changes in the environment, namely absence focal adhesion and strong confinement,
trigger the switch inmotility behavior. Liu et al. analyze a large set of different slowmesenchymal cells and show that the requirements
for the motility switch are universal. Rupretch et al. demonstrate that in vivo, during zebrafish development, fluctuations in cortical
contraction forces act in in concert with confinement and low adhesiveness, allow-
ing embryonic progenitor cells to acquire a fast and persistent migratory behavior.Viruses Gang Up
PAGE 619
A central paradigm in virology is that each virus largely behaves as an independent
infectious unit. Chen et al. now demonstrate that clusters of enteroviruses are pack-
aged within phosphatidylserine (PS)-enriched vesicles that are nonlytically released
from cells. Viruses within these vesicles have enhanced infection efficiency, and PS
lipids serve as cofactors for enterovirus receptors. Clustering viruses within vesicles
enables multiple viral genomes to be collectively transferred into cells, facilitating
genetic cooperativity among viral quasispecies and promoting viral replication.Cell 160, February 12, 2015 ª2015 Elsevier Inc. 571
Curbing Pain
PAGE 759
Inflammatory pathways stimulate the capsaicin receptor TRPV1, leading to pain hypersensitivity.
Hanack et al. identify a feedback mechanism that keeps TRPV1-mediated pain in check and could
lead to new avenues for analgesic therapy. Release of the neurotransmitter GABA in response to
TRPV1 activity triggers a noncanonical signaling pathway that inhibits only hyperactive TRPV1, leav-
ing homeostatic pain responses intact.
Catastrophic Cure
PAGE 686
Chromothripsis is a catastrophic cellular event, first described in cancer, in which chromosomes are
shattered and pieced back together imperfectly. McDermott et al. report a remarkable case in which a womanwithWHIM syndrome,
an inherited immunodeficiency disease, was fortuitously cured by a chromothriptic event in a single hematopoietic stem cell that
deleted the abnormal copy of the disease gene. This cell then took over the bone marrow and restored normal immune function.
Complement-ing Tumor Suppression
PAGE 700
Macrophages have a crucial role in mediating inflammation that contributes to development of cancer. Bonavita et al. report that
deficiency of PTX3, a soluble mediator that regulates Complement activity, is associated with cancer in humans and causes
tumor-promoting macrophage recruitment, angiogenesis, and Trp53mutations in mice. Thus, PTX3 acts as a physiological extrinsic
oncosuppressor inhibiting tumor generation through modulation of the activity of macrophages.
A Malignant Energy Switch
PAGE 715
AMPK is themaster regulator of cellular energyhomeostasis,with tumor suppressive activity. Pinedaet al. describe awidespreadmech-
anismbywhichAMPK is inactivated in cancer. Cancer-specificMAGE-A3/6-TRIM28E3ubiquitin ligase is anoncogenic driver that ubiq-
uitinates and degrades AMPKa1, resulting in downregulation of autophagy and increased mTOR signaling. These findings identify the
mechanism of action of theMAGE-A3/6 cancer-testis antigens and illustrate a regulatory axis for altering cellular metabolism in cancer.
Chaotic Therapy for Cancer
PAGE 729
The ERK kinase has been long thought to be the only substrate of MEK. Tang et al. now find that HSF1, the master regulator of pro-
teotoxic stress responses, is a newMEK substrate. MEK blockade inactivates HSF1 and provokes proteomic chaos. Tumor cells are
particularly susceptible to proteostasis disruption. In fact, amyloidogenesis induced by MEK inhibition suppresses tumor growth,
suggesting that disruptions of the fragile tumor proteostasis may be feasible as therapeutic strategy.
Inflaming Metabolic Dysfunction
PAGE 745
A high-fat diet is associated with several metabolic abnormalities such as hyperglycemia and increased rates of hepatic glucose pro-
duction. Perry et al. demonstrate that these abnormalities are primarily caused by increased macrophage-derived IL-6 levels in white
adipose tissue that results in impaired lipolysis and a concomitant increase in acetyl coA levels that fuel hepatic glucose production.
Inflammation, thus, is likely the underlying trigger of metabolic dysfunction associated with a high-fat diet.
Constant Change Is the Mother of All Frustration
PAGE 785
Pathogens suchasHIVand influenzaarehighlymutable. Their neutralization requires thegenerationof antibodies that cross-reactwith
different viral strains, which it is hard to achieve. Using an in silico approach,Wang et al. find that cross-reactive antibodies occur with
low probability because conflicting selection forces, imposed by the presence of different variants of
the sameantigen, frustrate affinitymaturation. Importantly, frustration canbeovercomeby sequential
immunization approaches.
Conformity Quells Resistance
PAGE 771
Manydiseases that readily evolve drug resistance are causedby cell populations that acquire diverse
karyotypes or chromosome copy number. Chen et al. find that growth-suppressing stresses only
serve to increase the heterogeneity of aneuploid populations, causing resistance to emerge. Using
a fungal pathogen as a model system, the authors propose and test a strategy termed an ‘‘evolu-
tionary trap’’ to eradicate such populations. One stress is applied to homogenize the population
via adaptation; a second specifically targets and eliminates the new newly dominant karyotype.Cell 160, February 12, 2015 ª2015 Elsevier Inc. 573
